Enfusion (NYSE:ENFN) Lowered to Sell at Zacks Investment Research

Enfusion (NYSE:ENFN – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Monday, Zacks.com reports. According to Zacks, “Enfusion Inc. is a provider of cloud-based investment management software and services. Through its software, analytics and middle/back-office managed services, it creates enterprise-wide cultures […]

Related Keywords

United States ,Stifel Nicolaus ,Asia Pacific ,Piper Sandler ,Morgan Stanley ,Enfusion Inc ,Credit Suisse Group ,Zacks Investment Research ,Hhlr Advisors ,Dragoneer Investment Group ,Blackrock Inc ,Timessquare Capital Management ,Goldman Sachs Group ,Get Rating ,Suisse Group ,Investment Group ,Square Capital Management ,Middle East ,Enfusion ,Nyse Enfn ,Enfn ,Computer And Technology ,Downgrade ,